Lack of association of polymorphisms of the lymphotoxin α gene with myocardial infarction in Japanese

Journal of Molecular Medicine

Volumn 82, Issue 7, 2004, Pages 477-483

  Yamada, Akira ^a,c   Ichihara, Sahoko ^a,b   Murase, Yosuke ^a   Kato, Tomoko ^a   Izawa, Hideo ^a   Nagata, Kohzo ^a   Murohara, Toyoaki ^a   Yamada, Yoshiji ^b   Yokota, Mitsuhiro ^a,c  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetes type 2; Genetic risk; Lymphotoxin gene; Myocardial infarction; Polymorphism

Indexed keywords

DNA; LYMPHOTOXIN;

ADULT; AGED; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA DETERMINATION; ETHNIC GROUP; FEMALE; FLUORESCENCE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEART INFARCTION; HUMAN; LYMPHOTOXIN ALPHA GENE; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

AGED; CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; IMMUNE SYSTEM; INFLAMMATION; JAPAN; LINKAGE DISEQUILIBRIUM; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; VASCULITIS;

EID: 3843138430     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bozzoni F, Beutler B (1996) The tumor necrosis factor ligand and receptor families. N Engl J Med 334:1717-1725
2. Campbell RD, Trowsdale J (1993) Map of the human MHC. Immunol Today 14:349-352
3. Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS (1990) Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol 65:297-302
4. Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS (1990) Tumor necrosis factor gene expression in human vascular intimal smooth muscle cells detected by in situ hybridization. Am J Pathol 137:503-509
5. Witte JS, Palmer LJ, O'Connor RD, Hopkins PJ, Hall JM (2002) Relation between tumour necrosis factor polymorphism TNF α-308 and risk of asthma. Eur J Hum Genet 10:82-85
6. Takeuchi K, Maijima Y, Sakakura Y (2000) Tumor necrosis factor gene polymorphism in chronic sinusitis. Laryngoscope 110:1711-1714
7. Martinez A, Fernandez-Arquero M, Pascual-Salcedo D, Conejero L, Alves H, Balsa A, dela Concha EG (2000) Primary association of tumor necrosis factor-region genetic markers with susceptibility to rheumatoid arthritis. Arthritis Rheum 43:1366-1370
8. Szalai C, Duba J, Prohaszka Z, Kalina A, Szabo T, Naqy B, Horvath L, Csaszar A (2001) Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1-2518 G/G genotype in CAD patients. Atherosclerosis 158:233-239
9. McDermott DH, Halcox JP, Schenke WH, Waclawiw MA, Merrell MN, Epstein N, Quyyumi AA, Murphy PM (2001) Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circ Res 89:401-407
10. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, Willeit J, Schwartz DA (2002) Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347:185-192
11. Ozaki K, Ohnishi Y, Iida A, Sekine A, Yamada R, Tsunoda T, Sato H, Sato H, Hori M, Nakamura Y, Tanaka T (2002) Functional SNPs in the lymphotoxin α gene that are associated with susceptibility to myocardial infarction. Nat Genet 32:650-654
12. Messer G, Spengler U, Jung MC, Honold G, Blomer K, Page GR, Riethmuller G, Weiss EH (1991) Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-β gene correlates with a variant amino acid in position 26 and a reduced level of TNF-β production. J Exp Med 173:209-219
13. Lewontin RC (1995) The detection of linkage disequilibrium in molecular sequence data. Genetics 140:377-388
14. Hill WG, Robertson A (1968) The effects of inbreeding at loci with heterozygote advantage. Genetics 60:615-628
15. Koch W, Kastrati A, Bottiger C, Mehilli J, von Beckerath N, Schomiq A (2001) Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 159:137-144
16. Koch W, Tiroch K, von Beckerath N, Schomiq A, Kastrati A (2003) Tumor necrosis factor-α, lymphotoxin-α, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting. Cytokine 24:161-171
17. Walton B, Willerson JT, Coresh J, Boerwinkle E (2003) Thrombospondin-2 and lymphotoxin-α gene variations predict coronary heart disease in a large prospective study. Circulation 108 [Suppl IV]:771
18. Agerholm-Larsen B, Nordestgarrd BG, Steffensen R, Sorensen TIA, Jensen G, Tybjarg-Hansen A (1997) ACE gene polymorphism: ischemic heart disease and longevity in 10150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study. Circulation 95:2358-2367
19. 677T gene polymorphism is associated with the extent of coronary atherosclerosis in patients at high risk for coronary artery disease. Eur Heart J 20:584-592
20. Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, Hirayama H, Sone T, Tanaka M, Yokota M (2002) Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347:1916-1923
21. Mannuci PM, Peyvandi F, Ardissino D, Yamada Y, Yokota M (2003) Risk of myocardial infarction and polymorphisms in candidate genes. N Engl J Med 348:1176-1177
22. Kankova K, Marova I, Jansen EH, Vasku A, Jurajda M, Vacha J (2002) Polymorphism NcoI in tumor necrosis factor B is associated with fasting glycemia and lipid parameters in healthy non-obese Caucasian subjects. Diabetes Metab 28:231-237
23. Braun J, Marz W, Winkelmann BR, Donner H, Henning Usadel K, Badenhoop K (1998) Tumour necrosis factor β alleles and hyperinsulinaemia in coronary artery disease. Eur J Clin Invest 28:538-542
24. DeFronzo RA, Ferrannini E (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194